CU Anschutz trial reports fewer heavy drinking days on oral semaglutide

The wire

1. 01Investigators at the University of Colorado Anschutz say their clinical trial of oral semaglutide found participants recorded fewer heavy drinking days.
2. 02Alcohol use disorder is the most-watched off-label question for incretins, and prescribers are already fielding patient requests based on anecdotal reports.
3. 03The institution's announcement does not provide sample size, dose or effect size here; clinicians should wait for the published trial report before drawing conclusions.

From the source

Can Oral Semaglutide Reduce Alcohol Use? CU Anschutz Clinical Trial Shows Fewer Heavy Drinking Days